Clinical Trials Browser

Cytopenia, Myelodysplastic Syndromes, Neoplasms, Leukemia, Myeloid, Acute

NCT06802146 2026-04-23

Early Intervention in High Risk CCUS

Phase EARLY_PHASE1 Recruiting

108 enrolled

Classical hematology

Cytopenia

NCT02958462 2026-02-23

Pre-myeloid Cancer and Bone Marrow Failure Clinic Study

Phase NA Recruiting

2,000 enrolled

Classical hematologyOther hematologic neoplasm

Bone Marrow Failure Disorders, Congenital Bone Marrow Failure Syndromes, Cytopenia, Neoplastic Syndromes, Hereditary, Hematologic Neoplasms

NCT06430788 2025-12-17

A Study of Emapalumab for Pediatric Aplastic Anemia

Phase 2 Recruiting

35 enrolled

Classical hematology

Bone Marrow Failure Disorders, Cytopenia, Anemia, Aplastic

NCT02143830 2025-11-12

RAFA

Phase 2 Recruiting

70 enrolled

Classical hematologyMyeloidOther hematologic neoplasm

Cytopenia, Anemia, Refractory, with Excess of Blasts, Fanconi Anemia, Myelodysplastic Syndromes, Leukemia, Myeloid, Acute

NCT06773871 2025-08-19

HemEx

Phase NA Recruiting

36 enrolled

Classical hematologyMyeloid

Cytopenia, Myelodysplastic Syndromes

NCT04741945 2024-11-22

Repurposing Metformin As a Leukemia-preventive Drug in CCUS and LR-MDS

Phase 2 Recruiting

40 enrolled

Classical hematologyOther hematologic neoplasm

Cytopenia, Anemia, Refractory, with Excess of Blasts, Preleukemia

NCT06439173 2024-06-03

Study of the Hematopoietic Niche and the Role of Inflammation in the Pathophysiology of Cytopenias After CAR-T Cell Therapy: Potential of Therapies Directed to Repair the Bone Marrow Microenvironment

Recruiting

40 enrolled

Classical hematologyLymphoid

Cytopenia, Inflammation, Lymphoma, B-Cell, Lymphoma, Large B-Cell, Diffuse

Clinical Trials

Comprehensive Molecular and Clinical Evaluation of Pediatric and Adult MDS

Early Intervention in High Risk CCUS

Pre-myeloid Cancer and Bone Marrow Failure Clinic Study

A Study of Emapalumab for Pediatric Aplastic Anemia

RAFA

HemEx

Repurposing Metformin As a Leukemia-preventive Drug in CCUS and LR-MDS

Study of the Hematopoietic Niche and the Role of Inflammation in the Pathophysiology of Cytopenias After CAR-T Cell Therapy: Potential of Therapies Directed to Repair the Bone Marrow Microenvironment